Report cover image

Analgesics in France

Published Oct 16, 2025
Length 25 Pages
SKU # EP20490730

Description

Sales of analgesic have seen stronger growth in 2025 compared to 2024, in current value terms. This is linked in part to a more severe cold and flu season in winter 2024/2025, with consumers’ still being impacted by weaker immune systems in the post-pandemic period. France saw the circulation of three flu viruses as well as a new strain of COVID-19, which put a strain on the public health system as well as driving demand for analgesics as consumers looked for relief from the symptoms.

Euromonitor International's Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

25 Pages
Analgesics in France
Euromonitor International
October 2025
List Of Contents And Tables
ANALGESICS IN FRANCE
KEY DATA FINDINGS
2025 DEVELOPMENTS
Analgesics continues to report healthy growth in 2025
Doliprane remains on top while ibuprofen brands suffer from negative media articles
Pharmacies and e-commerce monopolise distribution despite campaign to ease restrictions
PROSPECTS AND OPPORTUNITIES
Analgesics set for continued growth despite the challenges facing the market
Fears of shortages over as France looks to invest in local production
Herbal/traditional products could gain ground while the distribution landscape will remain under debate
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2020-2025
Table 2 Sales of Analgesics by Category: % Value Growth 2020-2025
Table 3 NBO Company Shares of Analgesics: % Value 2021-2025
Table 4 LBN Brand Shares of Analgesics: % Value 2022-2025
Table 5 Forecast Sales of Analgesics by Category: Value 2025-2030
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030
CONSUMER HEALTH IN FRANCE
EXECUTIVE SUMMARY
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
Table 8 Life Expectancy at Birth 2020-2025
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2020-2025
Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025
Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025
Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025
Table 14 Distribution of Consumer Health by Format: % Value 2020-2025
Table 15 Distribution of Consumer Health by Format and Category: % Value 2025
Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2024-2025
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.